Trials / Conditions / Persistent Corneal Epithelial Defect

Persistent Corneal Epithelial Defect

10 registered clinical trials studyying Persistent Corneal Epithelial Defect — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED NCT07519902	Dompé Farmaceutici S.p.A	Phase 3
Recruiting	Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease NCT06919081	University of Illinois at Chicago	Phase 2
Recruiting	A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED NCT05966493	Glaukos Corporation	Phase 2
Terminated	Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED NCT05727878	Combangio, Inc	Phase 2
Completed	A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects NCT05436288	Kiora Pharmaceuticals, Inc.	Phase 2
Terminated	ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects NCT05066698	Noveome Biotherapeutics, formerly Stemnion	Phase 2
Withdrawn	Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers NCT05172349	TBF Genie Tissulaire	Phase 2
Completed	ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects NCT03687632	Noveome Biotherapeutics, formerly Stemnion	Phase 2
Completed	Autologous Platelet Lysate in Corneal Epithelial Defects NCT02979912	Hanan Jafar	Phase 1 / Phase 2
Completed	Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect NCT00988494	Santen Pharmaceutical Co., Ltd.	Phase 2